AZD7507
AZD7507 is a potent and orally active CSF-1R inhibitor, with antitumor activity.
Product Specifications
CAS Number
1041852-85-0
Product Name Alternative
CXD101
UNSPSC
12352005
Hazard Statement
H302
Target
C-Fms
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD7507.html
Purity
99.57
Solubility
DMSO : 130 mg/mL (ultrasonic)
Smiles
O=C(N)C1=NN=C2C=C(C(N3CCN(CC3)CCO)=CC2=C1NC4=CC=C(C=C4F)C)OC
Molecular Formula
C23H27FN6O3
Molecular Weight
454.50
Precautions
H302
References & Citations
[1]Scott DA, et al. Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507. Bioorg Med Chem Lett. 2013 Aug 15;23 (16) :4591-6.|[2]Boulter L, et al. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. Send to J Clin Invest. 2015 Mar 2;125 (3) :1269-85.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0419303 1.0 µg DNA
CDKL4 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
MBS6448526-01 0.1 mL
PNLIP (PL, PTL, PNLIPD, Pancreatic Triacylglycerol Lipase) (PE)
Sign In for Pricing
View Details MBS6448526-02 5x 0.1 mL
PNLIP (PL, PTL, PNLIPD, Pancreatic Triacylglycerol Lipase) (PE)
Sign In for Pricing
View Details 
